参考文献/References:
[1]Wong HL,Christie M,Gately L,et al.Mismatch repair deficiency assessment by immunohistochemistry:for Lynch syndrome screening and beyond[J].Future Oncol,2018(14):2725-2739.[2]Ryan NAJ,Evans DG,Green K,et al.Pathological features andclinical behavior of Lynch syndrome -associated ovarian cancer[J].Gynecol Oncol,2017,144(3):491-495.[3]Siegel RL,Miller KD,Jemal A.Cancer statistics,2018[J].Ca Cancer J Clin,2017(67):7.[4]Shih IeM,Kurman RJ.Ovarian tumorigenesis:a proposed model based on morphological and molecular genetic analy-sis[J].Am J Pathol 2004(164):1511-1518.[5]Prat J,D’Angelo E,Espinosa I.Ovarian carcinomas:at least fivedifferent diseases with distinct histological features and molecular genetics[J].Hum Pathol,2018(80):11-27. [6]Prat J.Ovarian carcinomas:five distinct diseases with differentorigins,genetic alterations,and clinicopathological features[J].Virchows Arch,2012(460):237-249.[7]Biller LH,Syngal S,Yurgelun MB.Recent advances in Lynch syndrome[J].Fam Cancer,2019(18):211-219.[8]Duraturo F,Liccardo R,De Rosa M,et al.Genetics,diagnosis andtreatment of Lynch syndrome:Old lessons and current challenges[J].Oncol Lett,2019,17(3):3048-3054.[9]Javier García-Pérez,María Felicitas López-Cima,Beatriz Pérez-Gómez,et al.Mortality due to tumours of the digestive system in towns lying in the vicinity of metal production and processing installations[J].ence of the Total Environment,2010,408(16):3102-3112.[10]Moreira L,Balaguer F,Lindor N,et al.Identification of Lynch syndrome among patients with colorectal cancer[J].JAMA,2012,308(15):1555-1565.[11]Morak M,Kasbauer S,Kerscher M,et al.Loss of MSH2 and MSH6due to heterozygous germline defects in MSH3 and MSH6[J].FamCancer,2017,16(4):491-500.[12]de Barros AC,Takeda AAS,Dreyer TR,et al.DNA mismatch repairproteins MLH1 and PMS2 can be imported to the nucleus by aclassical nuclear import pathway[J].Biochimie,2018(146):87-96.[13]Poulogiannis G,Frayling IM,Arends MJ.DNA mismatch repair defificiency in sporadic colorectal cancer and Lynch syndrome[J].Histopathology,2010(56):167-179.[14]Stojic L,Mojas N,Cejka P,et al.Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase[J].Genes Dev,2004(18):1331-1344.[15]Sameer A,Nissar S,Fatima K.Mismatch repair pathway:molecules,functions,and role in colorectal carcinogenesis[J].Eur J Cancer Prev,2014(23):246-257. [16]Martin LP,Hamilton TC,Schilder RJ.Platinum resistance:the role of DNA repair pathways[J].Clin Cancer Res,2008(14):1291-1295.[17]Bartosch C,Clarke B,Bosse T.Gynaecological neoplasms in commonfamilial syndromes(Lynch and HBOC)[J].Pathology,2018,50(2):222-237.[18]Mills AM,Longacre TA.Lynch Syndrome Screening in theGynecologic Tract:Current State of the Art[J].Am J Surg Pathol,2016,40(4):e35-e44.[19]Moldovan R,Keating S,Clancy T.The impact of risk-reducinggynaecological surgery in premenopausal women at high risk ofendometrial and ovarian cancer due to Lynch syndrome[J].FamCancer,2015,14(1):51-60.[20]Lu KH,Dinh M,Kohlmann W,et al.Gynecologic cancer as a’sentinel cancer’ for women with hereditary nonpolyposis colorectal cancer syndrome[J].Obstet Gynecol,2005,105(3):569-574.[21]Sinicrope FA.Lynch Syndrome-Associated Colorectal Cancer [J].N Engl J Med,2018,379(8):764-773.[22]王甜甜,张蓉.林奇综合征与妇科肿瘤[J].国际妇产科学杂志,2016,43(5):497-501.[23]Helder-Woolderink JM,Blok EA,Vasen HF,et al.Ovarian cancer inLynch syndrome;a systematic review[J].Eur J Cancer,2016(55):65-73.[24]Chalmers ZR,Connelly CF,Fabrizio D,et al.Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden[J].Genome Med,2017,9(1):34.